Overproduction of K1 Enzyme in Klebsiella oxytoca Clinical Isolates Against Ceftazidime, Cefepime and Ceftobiprole

被引：0
|
作者：
Corvec, S. [1 ]
Cremet, L. [1 ]
Lepelletier, D. [1 ]
Reynaud, A. [1 ]
Drugeon, H. [1 ]
机构：
[1] CHU Nantes, Serv Bacteriol Hyg Hosp, F-44049 Nantes 01, France
来源：
JOURNAL OF CHEMOTHERAPY | 2009年 / 21卷 / 03期
关键词：
D O I：
10.1179/joc.2009.21.3.365
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：365 / 366
页数：2
相关论文
共 50 条
  • [41] In Vitro Activity of Cefepime-Zidebactam, Ceftazidime-Avibactam, and Other Comparators against Clinical Isolates of Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii: Results from China Antimicrobial Surveillance Network (CHINET) in 2018
    Yang, Yang
    Guo, Yan
    Yin, Dandan
    Zheng, Yonggui
    Wu, Shi
    Zhu, Demei
    Hu, Fupin
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (01)
  • [42] Comparative activity of tigecycline, cefepime and imipenem against clinical isolates of Klebsiella pneumoniae producing extended spectrum β-lactamases, plasmid-mediated AmpC-type β-lactamases or both, associated or not with porin deficiency
    Conejo, M.
    Hernández, J.
    Pasual, A.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S199 - S199
  • [43] Isolation and characterization of lytic phage TUN1 specific for Klebsiella pneumoniae K64 clinical isolates from Tunisia
    Simone Eckstein
    Jana Stender
    Sonia Mzoughi
    Kilian Vogele
    Jana Kühn
    Daniela Friese
    Christina Bugert
    Susann Handrick
    Mustapha Ferjani
    Roman Wölfel
    Andrew Millard
    Mohamed Ben Moussa
    Joachim J. Bugert
    BMC Microbiology, 21
  • [44] Isolation and characterization of lytic phage TUN1 specific for Klebsiella pneumoniae K64 clinical isolates from Tunisia
    Eckstein, Simone
    Stender, Jana
    Mzoughi, Sonia
    Vogele, Kilian
    Kuehn, Jana
    Friese, Daniela
    Bugert, Christina
    Handrick, Susann
    Ferjani, Mustapha
    Woelfel, Roman
    Millard, Andrew
    Ben Moussa, Mohamed
    Bugert, Joachim J.
    BMC MICROBIOLOGY, 2021, 21 (01)
  • [45] Isolation, Characterization, and Anti-Biofilm Activity of a Novel Kaypoctavirus Against K24 Capsular Type, Multidrug-Resistant Klebsiella pneumoniae Clinical Isolates
    Wintachai, Phitchayapak
    Santini, Joanne M.
    Thonguppatham, Renuka
    Stroyakovski, Maria
    Surachat, Komwit
    Atipairin, Apichart
    ANTIBIOTICS-BASEL, 2025, 14 (02):
  • [46] A Response to Article "Distribution of Mcr-1 Harboring Hypervirulent Klebsiella Pneumoniae in Clinical Specimens and Lytic Activity of Bacteriophage KpnM Against Isolates" [Letter]
    Panjaitan, Novaria Sari Dewi
    Lestari, Christina Safira Whinie
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 6007 - 6008
  • [47] Antiviral activity of tenofovir alafenamide (TAF) against HIV-1 clinical isolates harboring K65R
    Cox, Stephanie
    Margot, Nicolas
    Callebaut, Christian
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (04)
  • [48] Impact of ompk36 genotype and KPC subtype on the in vitro activity of ceftazidime/avibactam, imipenem/relebactam and meropenem/vaborbactam against KPC-producing K. pneumoniae clinical isolates
    Rogers, Tara M.
    Kline, Ellen G.
    Griffith, Marissa P.
    Jones, Chelsea E.
    Rubio, Abigail M.
    Squires, Kevin M.
    Shields, Ryan K.
    JAC-ANTIMICROBIAL RESISTANCE, 2023, 5 (02):
  • [49] A Response to Article "Distribution of Mcr-1 Harboring Hypervirulent Klebsiella pneumoniae in Clinical Specimens and Lytic Activity of Bacteriophage KpnM Against Isolates" [Response to Letter]
    Aslam, Bilal
    Khurshid, Mohsin
    Ahmad, Moeed
    Baloch, Zulqarnain
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 6601 - 6602
  • [50] Association of blaNDM-1 with blaKPC-2 and aminoglycoside-modifying enzyme genes among Klebsiella pneumoniae, Proteus mirabilis and Serratia marcescens clinical isolates in Brazil
    Firmo, Elza Ferreira
    Bispo Beltrao, Elizabeth Maria
    Ferreira da Silva, Felipe Rogerio
    Alves, Luis Carlos
    Brayner, Fabio Andre
    Veras, Dyana Leal
    Souza Lopes, Ana Catarina
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 21 : 255 - 261
12345